GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. 

Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). 

GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases.  

For more information, please visit www.genesispharmagroup.com and www.genesispharma.com

Pharmaceutical

Life Sciences

Biotechnology

GENESIS Pharma

GENESIS Pharma's headquarters in Athens, Greece

Costas Evripides

Edward Lysen

Alexandros Evripides

Spyros Tsoutsouras

George Vogiatzis

Nikolaos Antonakopoulos

Stelios Prodromou

Sofia Egglezou

Description

People (5)

Nikos Papadeas

Bertzeletou M.

Eleni Stathouli

Georgios Zavitsanakis

Alexios Giotis

Jobs